Sylvia Snauwaert

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

Laëtitia Vercellino, Anne‐Ségolène Cottereau, Olivier Casasnovas et al. · Blood · 2020 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +12

Specific Notch receptor–ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strength

Inge Van de Walle, Els Waegemans, Jelle De Medts et al. · The Journal of Experimental Medicine · 2013 · 100 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study

Franck Morschhauser, Steven Le Gouill, Pierre Feugier et al. · The Lancet Haematology · 2019 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study

Emmanuel Bachy, Roch Houot, Pierre Feugier et al. · Blood · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Sylvia Snauwaert, Stijn Vanhee, Glenn Goetgeluk et al. · Haematologica · 2012 · 34 citations · Full text

Medicine, Immunology, Oncology +15